scispace - formally typeset
Journal ArticleDOI

Lysozyme distribution in healthy human skin

Reads0
Chats0
TLDR
Forty hospitalized volunteers of both sexes, aged between 19 and 71 years, were studied and lysozyme activity was found to be between 1.25 and 18 lag/ml in serum and between 75 and 198 lag/g wet weigth in skin samples.
Abstract
Lysozyme is present in human skin as well as in other tissues and secretions [2, 4]. Previous personal investigations [1] demonstrated lysozyme activity of between 85 and 195 lag/g wet weight (average 142 lag/g wet weight) in the skin of clinically healthy subjects. Indirect immunofluorescence studies [3] revealed that lysozyme is mainly located in the cytoplasm of epidermal cells and that only small quantities are present along the dermal collagen bundles. Forty hospitalized volunteers of both sexes, aged between 19 and 71 years, were studied. All were free from clinical infections and had only limited traumatic or proliferative skin lesions. Lysozyme activity was determined in both serum and 0.5 mm thick samples of skin taken from the lumbar region and treated according to Binazzi et al. [1]. Histochemical studies were carried out on fine frozen sections of skin removed from the same area and/or from the internal surface of the forearm in an identical condition. Immunofluorescence was performed by the routine technique using antihuman milk muramidase rabbit IgG (Dakopatts, Denmark) and ITCF-labeled antl-~rabbit IgG swine serum (Dakopatts, Denmark). The peroxidase conjugate method (Table 1) was used for the immunoperoxidase studies. Controls were performed by absorbing the primary anti-human muramidase antiserum on purified human milk lysozyme before immunostaining, thus blocking the reactivity for muramidase. Lysozyme activity was found to be between 1.25 and 18 lag/ml (average 5.15 lag/M) in serum and between 75 and 198 lag/g wet weigth (average 119.5 lag/g wet weight) in skin samples. These results did not show significant differences with respect to those previously reported [1].

read more

Citations
More filters
Journal ArticleDOI

Antimicrobial skin peptides and proteins.

TL;DR: It is suggested that non-inflammatory stimuli of endogenous and/or exogenous origin can also stimulate AMP synthesis without inflammation and might be ideal ‘immune stimulants’ to induce only the innate antimicrobial skin effector molecules without causing inflammation.
Journal ArticleDOI

Psoriatic scales : a promising source for the isolation of human skin-derived antimicrobial proteins

TL;DR: This review will focus on the most prominent antimicrobial proteins in psoriatic‐scale extracts, which are identified as the S100‐protein psoriasin, human β‐defensin 2, RNase 7, lysozyme, and human neutrophil defensin 1–3.
Journal ArticleDOI

Differential Gene Induction of Human β-Defensins (hBD-1, -2, -3, and -4) in Keratinocytes Is Inhibited by Retinoic Acid

TL;DR: RA is a potent inhibitor of beta-defensin induction in keratinocytes and might downregulate the inducible innate chemical defense system of human skin.
Journal ArticleDOI

Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents.

TL;DR: The present review briefly examines the infections caused by Candida species and focuses on the mechanisms of action associated with the traditional agents used to treat those infections, as well as the current understanding of the molecular basis of resistance development in these fungal species.
References
More filters
Journal ArticleDOI

The distribution of muramidase (lysozyme) in human tissues.

TL;DR: The distribution of muramidase (lysozyme) in normal and pathological human tissues has been studied, using an immunohistological technique, and the most striking positivity was encountered in reactive histiocytic cells in granulomatous conditions such as tuberculosis and Crohn's disease.
Journal Article

Human lysozyme (origin and distribution in health and disease).

TL;DR: Histochemical and in particular immunoperoxidase techniques have extended knowledge about the cellular distribution of LZM, and evidence is accumulating which suggests that the enzyme might have other functions as well.
Journal ArticleDOI

Immunocytological localization of lysozyme in human skin.

TL;DR: Antibody against human lysozyme was purified from sera of immunized rabbits using the immuno‐absorption technique to produce antibodies against human Lysozyme.
Journal ArticleDOI

Serum and skin lysozyme activity in non-diabetic and diabetic subjects.

TL;DR: Lysozyme activity was significantly reduced in the skin of patients with clinical diabetes, but not in theSkin of other diabetics or in serum of all these patients.
Related Papers (5)